Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes-Reference-Cited by-同舟云学术

Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes

Published:2009-02 Issue:2 Volume:19 Page:237-264
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Bharate Sandip B,Nemmani Kumar VS,Vishwakarma Ram A

Publisher

Informa Healthcare

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/13543770802665717

Reference46 articles.

1. Stimulation of insulin secretion by infusion of free fatty acids

2. Seven Transmembrane-spanning Receptors for Free Fatty Acids as Therapeutic Targets for Diabetes Mellitus: Pharmacological, Phylogenetic, and Drug Discovery Aspects

3. Free Fatty Acid Receptors and Drug Discovery

4. Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40

5. The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural hypoglycaemic bioactives: Newer avenues and newer possibilities;Phytotherapy Research;2024-07-11

2. Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationships;European Journal of Medicinal Chemistry;2024-01

3. Identification of behenic acid as medicinal food for the diabetes mellitus: structure-based computational approach and molecular dynamics simulation studies;Journal of Molecular Modeling;2022-02-28

4. Ligand and structure-based computational designing of multi-target molecules directing FFAR-1, FFAR-4 and PPAR-G as modulators of insulin receptor activity;Journal of Biomolecular Structure and Dynamics;2021-03-02

5. Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus;Mini-Reviews in Medicinal Chemistry;2021-02-16